Structural and functional basis for p38-MK2-activated rsk signaling in toll-like receptor-stimulated dendritic cells

Molecular and Cellular Biology

Volumn 35, Issue 1, 2015, Pages 132-140

  Zaru, Rossana ^a   Edgar, Alexander J ^a   Hanauer, André ^b   Watts, Colin ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLYCOGEN SYNTHASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; CYTOKINE; MAP-KINASE-ACTIVATED KINASE 2; PROTEIN SERINE THREONINE KINASE; RPS6KA1 PROTEIN, MOUSE; S6 KINASE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOPLASM; CYTOSOL; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FIBROBLAST; MOUSE; NONHUMAN; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; CELL PROLIFERATION; CYTOKINES; CYTOPLASM; CYTOSOL; DENDRITIC CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMATOPOIETIC STEM CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84920018062     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00773-14     Document Type: Article

References (47)

1. Cargnello M, Roux PP. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50-83. http://dx.doi.org/10.1128/MMBR.00031-10.
2. Deak M, Clifton AD, Lucocq LM, Alessi DR. 1998. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17:4426-4441.
3. Zaru R, Ronkina N, Gaestel M, Arthur JS, Watts C. 2007. The MAPKactivated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat Immunol 8:1227-1235. http://dx.doi.org/10.1038/ni1517.
4. Frodin M, Jensen C, Merienne K, Gammeltoft S. 2000. A phosphoserine- regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J 19:2924-2934. http://dx.doi.org/10.1093/emboj/19.12.2924.
5. Jensen CJ, Buch M, Krag T, Hemmings B, Gammeltoft S, Frodin M. 1999. 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J Biol Chem 274:27168-27176.
6. Fisher T, Blenis J. 1996. Evidence for two catalytically active kinase domains in pp90rsk. Mol Cell Biol 16:1212-1219.
7. Vik TA, Ryder JW. 1997. Identification of serine 380 as the major site of autophosphorylation of Xenopus pp90rsk. Biochem Biophys Res Commun 235:398-402.
8. Cohen MS, Hadjivassiliou H, Taunton J. 2007. A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nat Chem Biol 3:156-160. http://dx.doi.org/10.1038/nchembio859.
9. Reis e Sousa C. 2006. Dendritic cells in a mature age. Nat Rev Immunol 6:476-483. http://dx.doi.org/10.1038/nri1845.
10. Merad M, Sathe P, Helft J, Miller J, Mortha A. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563-604. http://dx.doi.org/10.1146/annurev-immunol-020711-074950.
11. Kawai T, Akira S. 2006. TLR signaling. Cell Death Differ 13:816-825. http://dx.doi.org/10.1038/sj.cdd.4401850.
12. Broz P, Monack DM. 2013. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 13:551-565. http://dx.doi.org/10.1038/nri3479.
13. Arthur JSC, Arthur JS, Ley SC. 2013. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13:679-692. http://dx.doi.org/10.1038/nri3495.
14. Kabelitz D. 2007. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol 19:39-45. http://dx.doi.org/10.1016/j.coi.2006.11.007.
15. Buchta CM, Bishop GA. 2014. Toll-like receptors and B cells: functions and mechanisms. Immunol Res 59:12-22. http://dx.doi.org/10.1007/s12026-014-8523-2.
16. Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. 2007. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol 37:2205-2213. http://dx.doi.org/10.1002/eji.200636984.
17. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: implication for Coffin-Lowry syndrome. Cell 117:387-398. http://dx.doi.org/10.1016/S0092-8674(04)00344-7.
18. West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, Ljunggren H, Prescott AR, Watts C. 2004. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305:1153-1157. http://dx.doi.org/10.1126/science.1099153.
19. Edgar AJ, Trost M, Watts C, Zaru R. 2014. A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870. Biosci Rep 34:29-41. http://dx.doi.org/10.1042/BSR20130094.
20. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122. http://dx.doi.org/10.1016/S1074-7613(00)80086-2.
21. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301: 640-643. http://dx.doi.org/10.1126/science.1087262.
22. Garai 'A, Zeke A, Gógl G, Töro I, Fördos F, Blankenburg H, Bárkai T, Varga J, Alexa A, Emig D, Albrecht M, Reményi A. 2012. Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove. Sci Signal 5:ra74. http://dx.doi.org/10.1126/scisignal.2003004.
23. Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ. 1998. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8:1049-1057.
24. Engel K, Kotlyarov A, Gaestel M. 1998. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 17:3363-3371. http://dx.doi.org/10.1093/emboj/17.12.3363.
25. Gaestel M. 2006. MAPKAP kinases - MKs - two's company, three's a crowd. Nat Rev Mol Cell Biol 7:120-130. http://dx.doi.org/10.1038/nrm1834.
26. Takahashi E, Abe J, Gallis B, Aebersold R, Spring DJ, Krebs EG, Berk BC. 1999. p90RSK is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. J Biol Chem 274:20206-20214.
27. Woo MS, Ohta Y, Rabinovitz I, Stossel TP, Blenis J. 2004. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol Cell Biol 24:3025-3035. http://dx.doi.org/10.1128/MCB.24.7.3025-3035.2004.
28. Sutherland C, Leighton I, Cohen P. 1993. Inactivation of glycogen synthase kinase-3b by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296:15-19.
29. Sapkota G, Cummings L, Newell F, Armstrong C, Bain J, Frodin M, Grauert M, Hoffmann M, Schnapp G, Steegmaier M, Cohen P, Alessi D. 2006. BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem J 401:29-38. http://dx.doi.org/10.1042/BJ20061088.
30. Kirrane TM, Boyer SJ, Burke J, Guo X, Snow RJ, Soleymanzadeh L, Swinamer A, Zhang Y, Madwed JB, Kashem M, Kugler S, O'Neill MM. 2012. Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity. Bioorg Med Chem Lett 22:738-742. http://dx.doi.org/10.1016/j.bmcl.2011.10.029.
31. Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, Lahoud MH, O'Keeffe M, Shao Q, Chen W, Villadangos JA, Shortman K, Wu L. 2005. Generation of splenic CD8+ and CD8-dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol 174:6592-6597. http://dx.doi.org/10.4049/jimmunol.174.11.6592.
32. Meng W, Swenson LL, Fitzgibbon MJ, Hayakawa K, ter Haar E, Behrens AE, Fulghum JR, Lippke JA. 2002. Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export. J Biol Chem 277:37401-37405. http://dx.doi.org/10.1074/jbc. C200418200.
33. White A, Pargellis CA, Studts JM, Werneburg BG, Farmer BT. 2007. Molecular basis of MAPK-activated protein kinase 2: p38 assembly. Proc Natl Acad Sci U S A 104:6353-6358. http://dx.doi.org/10.1073/pnas.0701679104.
34. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, van Dyke T, Pulendran B. 2003. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c- Fos. J Immunol 171:4984-4989. http://dx.doi.org/10.4049/jimmunol.171.10.4984.
35. Cros J, Cagnard N, Woollard K, Patey N, Zhang S, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, Jais J, D'Cruz D, Casanova J, Trouillet C, Geissmann F. 2010. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33:375-386. http://dx.doi.org/10.1016/j.immuni.2010.08.012.
36. Gilliet M, Cao W, Liu Y. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8:594-606. http://dx.doi.org/10.1038/nri2358.
37. McGuire VA, Gray A, Monk CE, Santos SG, Lee K, Aubareda A, Crowe J, Ronkina N, Schwermann J, Batty IH, Leslie NR, Dean JL, O'Keefe SJ, Boothby M, Gaestel M, Arthur JS. 2013. Cross talk between the Akt and p38alpha pathways in macrophages downstream of Toll-like receptor signaling. Mol Cell Biol 33:4152-4165. http://dx.doi.org/10.1128/MCB.01691-12.
38. Saraiva M, O'Garra A. 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181. http://dx.doi.org/10.1038/nri2711.
39. Zhang C, Baumgartner RA, Yamada K, Beaven MA. 1997. Mitogenactivated protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases. J Biol Chem 272: 13397-13402. http://dx.doi.org/10.1074/jbc.272.20.13397.
40. Kim C, Sano Y, Todorova K, Carlson BA, Arpa L, Celada A, Lawrence T, Otsu K, Brissette JL, Arthur JS, Park JM. 2008. The kinase p38α serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol 9:1019-1027. http://dx.doi.org/10.1038/ni.1640.
41. Dufresne SD, Bjorbaek C, El-Haschimi K, Zhao Y, Aschenbach WG, Moller DE, Goodyear LJ. 2001. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol Cell Biol 21:81-87. http://dx.doi.org/10.1128/MCB.21.1.81-87.2001.
42. Douville E, Downward J. 1997. EGF induced SOS phosphorylation in PC12 cells involves p90 RSK-2. Oncogene 15:373-383. http://dx.doi.org/10.1038/sj.onc.1201214.
43. Takauji R, Iho S, Takatsuka H, Yamamoto S, Takahashi T, Kitagawa H, Iwasaki H, Iida R, Yokochi T, Matsuki T. 2002. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J Leukoc Biol 72:1011-1019.
44. Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, Arthur JS, Flavell RA, Ghosh S, Paludan SR. 2009. RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1. J Biol Chem 284:10774-10782. http://dx.doi.org/10.1074/jbc. M807272200.
45. Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, Murthy N, Pulendran B. 2008. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 9:1157-1164. http://dx.doi.org/10.1038/ni.1645.
46. Laplante M, Sabatini D. 2012. mTOR signaling in growth control and disease. Cell 149:274-293. http://dx.doi.org/10.1016/j.cell.2012.03.017.
47. González-Navajas JM, Lee J, David M, Raz E. 2012. Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:125-135. http://dx.doi.org/10.1038/nri3133.